NASDAQ
Agile Therapeutics, Inc. (AGRX) has a free cash flow growth of 109.41% as of Friday, May 29, 2026. This represents a 122.77% increase compared to its 12-month average of -480.56%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.